Literature DB >> 1664808

Purification and immunochemical characterization of a recombinant outer membrane protein from Bacteroides gingivalis.

Y Kawamoto1, M Hayakawa, Y Abiko.   

Abstract

1. Bacteroides gingivalis is thought to be one of the most virulent microorganisms in relation to adult periodontitis. A gene clone, MD125, is an Escherichia coli host which produces an outer membrane protein of B. gingivalis. 2. The recombinant outer membrane protein (rOMP) was purified to homogeneity from cell sonicate of MD125 by four chromatographic steps. The molecular weight of the purified rOMP was estimated to be approximately 40 kDa. 3. Immunodiffusion analysis showed that antiserum against whole cells of B. gingivalis reacted not only with B. gingivalis cells but also with other Bacteroides cells. Antiserum against the purified recombinant protein reacted with cells of B. gingivalis, whereas this antiserum did not react with all of the other Bacteroides species tested. 4. These data suggest that the rOMP may be a B. gingivalis-specific antigen and that the purified rOMP will be useful material for serodiagnosis and for the development of a vaccine against B. gingivalis infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664808     DOI: 10.1016/0020-711x(91)90145-d

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  6 in total

1.  Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.

Authors:  Chenlu Liu; Tomomi Hashizume; Tomoko Kurita-Ochiai; Kohtaro Fujihashi; Masafumi Yamamoto
Journal:  Mol Oral Microbiol       Date:  2010-06       Impact factor: 3.563

2.  A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis.

Authors:  Y Abiko; N Ogura; U Matsuda; K Yanagi; H Takiguchi
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.

Authors:  Y Koizumi; T Kurita-Ochiai; S Oguchi; M Yamamoto
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

4.  Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium.

Authors:  D M Dusek; A Progulske-Fox; J Whitlock; T A Brown
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

5.  Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.

Authors:  Fumiki Momoi; Tomomi Hashizume; Tomoko Kurita-Ochiai; Yoshikazu Yuki; Hiroshi Kiyono; Masafumi Yamamoto
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

6.  Characterization of hemin-binding protein 35 (HBP35) in Porphyromonas gingivalis: its cellular distribution, thioredoxin activity and role in heme utilization.

Authors:  Mikio Shoji; Yasuko Shibata; Teruaki Shiroza; Hideharu Yukitake; Benjamin Peng; Yu-Yen Chen; Keiko Sato; Mariko Naito; Yoshimitsu Abiko; Eric C Reynolds; Koji Nakayama
Journal:  BMC Microbiol       Date:  2010-05-25       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.